1 / 1

Hereditary Angioedema Market

In 2017 the total diagnosed prevalent population of Hereditary Angioedema in 7MM was 14,435. In France the prevalent cases of Hereditary Angioedema was found to be 1,346, while the UK and Spain had 1,301 and 537 prevalent cases in 2017. <br><br>The Hereditary Angioedema Market Size was USD 1,741.75 million in seven major markets in 2017, which is expected to increase during the forecast period 2017-2030.<br><br>Rising prevalence, introduction of oral therapy and increase in R&D are some of the key factors expected to drive the Hereditary Angioedema Market forward in the coming years. <br><br>Some of the key players in the Hereditary Angioedema Market includes BioCryst Pharmaceuticals, Ionis Pharmaceuticals, KalVista Pharmaceuticals, CSL Behring, and many others. <br><br>For more detailed information on Hereditary Angioedema Market, visit: https://www.delveinsight.com/report-store/hereditary-angioedema-market<br><br>

DelveInsight
Download Presentation

Hereditary Angioedema Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related